Total Funding
77
64
Total FundingGrant raised
Growth Score
-6 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
91994
Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1.
Chris Wood: Founder, CMO, Executive ChairmanPast Role: Bioenvision, Co-Founder, Chairman and CEO
Ian Abercrombie: Chief Executive OfficerPast Role: Bioenvision, Team Member
About the Company
Medannex's goal is to create a first-in-class antibody therapy to improve the lives of people impacted by cancers and autoimmune diseases.
